ATLANTA, June 26, 2012 – Eleven King & Spalding lawyer have been identified as ‘life sciences stars’ in the first-ever edition of LMG Life Sciences. Published by Legal Media Group in association with Benchmark: Litigation, Managing IP, and IFLR, LMG Life Sciences aims to recognize the “highest profile, most sought-after and best-attorneys working in life sciences.”
In addition, the firm was ‘highly recommended’ by LMG Life Sciences in the area of FDA-medical device regulatory work and ‘recommended’ for both government investigations/ fraud & abuse and product liability matters on behalf of life sciences clients.
LMG Life Sciences bases its research on online surveys and interviews with lawyers across the United States. Its researchers also spoke to clients and leading lawyers within the industry and reviewed public information to inform their decisions.
The 2012 edition of LMG Life Sciences included the following King & Spalding lawyers:
- Edward M. Basile (Regulatory)
- Andy T. Bayman (Non-IP Litigation and Enforcement)
- Mark S. Brown (Regulatory)
- Gina M. Cavalier (Non-IP Litigation and Enforcement)
- Frederick H. Degnan (Regulatory)
- Mark A. Jensen (Non-IP Litigation and Enforcement)
- Christina M. Markus (Regulatory)
- Judy Mohr (Intellectual Property)
- John D. Shakow (Regulatory)
- J. Sedwick Sollers (Non-IP Litigation and Enforcement)
- Chilton Davis Varner (Non-IP Litigation and Enforcement)
King & Spalding’s FDA & Life Sciences practice focuses on representing pharmaceutical, medical device, biotechnology and other healthcare technology companies, as well as food manufacturers, in a wide range of regulatory, compliance, policy, and litigation matters. The group provides sophisticated counseling and advice to more than 100 drug and device manufacturers and others in the healthcare technology sector, including nine of the 25 largest pharmaceutical manufacturers, and 18 of the 25 largest device manufacturers.
About King & Spalding
Celebrating more than 125 years of service, King & Spalding is an international law firm that represents a broad array of clients, including half of the Fortune Global 100, with 800 lawyers in 17 offices in the United States, Europe, the Middle East and Asia. The firm has handled matters in over 160 countries on six continents and is consistently recognized for the results it obtains, uncompromising commitment to quality and dedication to understanding the business and culture of its clients. More information is available at www.kslaw.com.
